Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Clotblog with Dr Samuel Goldhaber
View all posts »Can we omit aspirin when anticoagulated patients undergo PCI?
Mar 1, 2013 08:30 EST-
0Comments
-
Read later
The WOEST study—which was presented at ESC 2012 and has been published in the Lancet—provides valuable clinical-trial data to the debate on double vs triple therapy in anticoagulated patients undergoing PCI. It's a thought-provoking study. Is it time to act on the results?
See also:
WOEST: Drop aspirin in stent patients on oral anticoagulants
Dewilde WJM, Verheugt FWA, Kelder JC, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 2013; epub ahead of print. Abstract.
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
